FDA NDC Directory · JSON-LD · Markdown

BLINCYTO

NDC 55513-160 · HUMAN PRESCRIPTION DRUG · KIT

Generic nameblinatumomab
Labeler / ManufacturerAmgen, Inc
Marketing categoryBiologic License Application · App BLA125557
Dosage form / routeKIT
Active ingredients—
Marketing started20141218
Package count2

External sources

Source: openFDA. Public-domain (CC0).